Key Takeaways
- In 2021, there were 11.9 million incident strokes globally, representing a 70% increase from 1990 levels according to the Global Burden of Disease Study
- The global age-standardized incidence rate of stroke decreased by 20% from 1990 to 2021, but total incident cases rose due to population growth and aging
- Ischemic stroke accounts for 62.4% of all incident strokes worldwide in 2021, per GBD 2021 data
- In 2021, 7.2 million people died from stroke globally, second leading cause of death, WHO 2023
- Stroke caused 6.55 million deaths in 2019, with age-standardized mortality rate of 87 per 100,000, GBD 2019
- Global age-standardized stroke mortality decreased 36% from 1990 to 2021, but total deaths rose 44%
- High blood pressure attributable to 51% of stroke deaths worldwide in 2019, GBD
- Smoking causes 15.6% of global stroke burden measured in DALYs, GBD 2019
- High body-mass index linked to 12% of stroke DALYs globally in 2021
- Only 42% of global stroke patients receive acute thrombolysis where available, INTERSTROKE study
- Thrombolysis with tPA within 4.5 hours reduces disability by 30% in ischemic stroke, AHA guidelines
- Endovascular thrombectomy improves outcomes in 46% of large vessel occlusion strokes up to 24 hours
- Global cost of stroke estimated at $891 billion annually in 2019, including direct and indirect costs
- Stroke costs represent 2.7% of total global disease burden in economic terms, GBD 2019
- In Europe, stroke costs €60 billion yearly, with 79% indirect costs from lost productivity
Stroke cases are rising globally due to aging populations, though prevention could address most causes.
Economic and Social Impact
- Global cost of stroke estimated at $891 billion annually in 2019, including direct and indirect costs
- Stroke costs represent 2.7% of total global disease burden in economic terms, GBD 2019
- In Europe, stroke costs €60 billion yearly, with 79% indirect costs from lost productivity
- US stroke economic burden $56.6 billion in 2020, projected to $109 billion by 2050
- LMICs face 75% of stroke economic burden despite 50% of GDP per capita, WHO
- Informal caregiving for stroke survivors costs $200 billion globally per year
- Stroke-related disability leads to 143 million YLDs globally in 2021
- In China, stroke direct medical costs $15 billion annually, rising with aging
- Productivity losses from stroke amount to 1.5% of GDP in low-income countries
- 50 million stroke survivors worldwide need long-term care, straining social services
- Global investment in stroke prevention yields $5 return per $1 spent, WHO modeling
- Stroke disability-adjusted life expectancy loss is 4.5 years per case globally
- In India, stroke costs 0.7% of GDP, mostly non-medical
- Gender disparity: women bear 60% higher long-term stroke care costs due to longevity
- Tele-rehabilitation reduces stroke care costs by 30% in remote areas, meta-analysis
- Global stroke prevalence leads to 102 million people with post-stroke depression, impacting economy
- Annual global direct healthcare costs for stroke exceed $500 billion
- In Australia, stroke indirect costs are $3.8 billion yearly from lost wages
- 70% of stroke survivors over 65 require social support services lifelong
Economic and Social Impact Interpretation
Incidence and Prevalence
- In 2021, there were 11.9 million incident strokes globally, representing a 70% increase from 1990 levels according to the Global Burden of Disease Study
- The global age-standardized incidence rate of stroke decreased by 20% from 1990 to 2021, but total incident cases rose due to population growth and aging
- Ischemic stroke accounts for 62.4% of all incident strokes worldwide in 2021, per GBD 2021 data
- Intracerebral hemorrhage represents 27.8% of global incident strokes in 2021, showing a slight decline from 1990
- Subarachnoid hemorrhage comprises 9.8% of incident strokes globally in 2021, with minimal change over three decades
- In low-income countries, stroke incidence rates are 1.5 times higher than in high-income countries when age-adjusted, WHO data 2023
- Global prevalence of stroke survivors reached 93.8 million in 2021, up 86% since 1990 due to improved survival, GBD 2021
- Eastern Sub-Saharan Africa has the highest age-standardized stroke prevalence at 1,456 per 100,000 in 2021
- High-income North America shows the lowest stroke prevalence at 712 per 100,000 age-standardized in 2021
- Women experience 12% higher stroke prevalence than men globally in 2021, adjusted for age
- Stroke incidence in people under 70 years increased by 40% globally from 1990 to 2021, GBD analysis
- Asia accounted for 61% of global stroke incidents in 2021, totaling 7.3 million cases
- Age-standardized stroke incidence fell 17% in high SDI regions but rose 58% in low SDI regions from 1990-2021
- In 2019, 84% of global stroke burden occurred in low- and middle-income countries (LMICs), WHO report
- Global stroke incidence rate for ages 50-69 was 300 per 100,000 in 2021, higher in males
- Central Europe had a 25% decline in stroke incidence rates from 1990 to 2021
- Tropical Latin America stroke prevalence is 1,120 per 100,000 age-standardized in 2021
- Global stroke incidents in 1990 were 7.0 million, rising to 11.9 million by 2021
- South Asia's stroke incidence increased 100% from 1990 to 2021 due to population factors
- Age-standardized prevalence of ischemic stroke globally is 890 per 100,000 in 2021
Incidence and Prevalence Interpretation
Mortality Rates
- In 2021, 7.2 million people died from stroke globally, second leading cause of death, WHO 2023
- Stroke caused 6.55 million deaths in 2019, with age-standardized mortality rate of 87 per 100,000, GBD 2019
- Global age-standardized stroke mortality decreased 36% from 1990 to 2021, but total deaths rose 44%
- Ischemic stroke mortality accounts for 44% of all stroke deaths in 2021 globally
- Intracerebral hemorrhage has the highest mortality rate at 42% case fatality globally, WHO data
- In low SDI regions, stroke mortality rate is 150 per 100,000 age-standardized in 2021
- High-income Asia Pacific has the lowest stroke mortality at 40 per 100,000 in 2021
- Stroke deaths in males are 10% higher than in females globally in 2021
- Eastern Sub-Saharan Africa stroke mortality rate is 179 per 100,000 age-standardized in 2021, highest globally
- From 1990-2021, stroke mortality in high SDI regions declined 51%
- In 2021, 160.5 million DALYs lost to stroke globally, up 32% since 1990, GBD
- Age-standardized stroke DALY rate fell 42% globally 1990-2021
- 44% of stroke deaths in 2021 were from ischemic stroke, 44% from ICH, 12% SAH
- LMICs account for 87% of stroke-related deaths worldwide, WHO 2023
- Global stroke mortality in under-70s is 2.5 million annually, rising trend
- Oceania stroke mortality declined 30% age-standardized 1990-2021
- In 2019, stroke ranked second in global deaths at 6.2 million for CVD category
- Central Asia stroke mortality rate 120 per 100,000 in 2021
- 30-day case fatality for stroke is 15-20% globally, varying by type, WHO
Mortality Rates Interpretation
Risk Factors
- High blood pressure attributable to 51% of stroke deaths worldwide in 2019, GBD
- Smoking causes 15.6% of global stroke burden measured in DALYs, GBD 2019
- High body-mass index linked to 12% of stroke DALYs globally in 2021
- Diabetes mellitus contributes to 8.5% of stroke-attributable DALYs worldwide
- Ambient particulate matter pollution causes 14.1% of stroke DALYs globally, GBD 2019
- 13.1% of strokes are attributable to high fasting plasma glucose levels globally
- Atrial fibrillation increases stroke risk 5-fold, affecting 33 million globally, WHO
- Hypertension prevalence is 1.28 billion adults worldwide, primary stroke risk
- Air pollution (PM2.5) exposure leads to 4.2 million stroke cases annually indirectly
- 80% of strokes are preventable through lifestyle changes like diet and exercise, WHO estimate
- High LDL cholesterol accounts for 10% of global stroke DALYs in 2019
- Kidney dysfunction contributes 7.5% to stroke burden worldwide, GBD
- Alcohol use causes 5.6% of stroke DALYs globally, dose-dependent risk
- Physical inactivity linked to 6.6% of stroke cases worldwide
- 25% of stroke patients have undiagnosed diabetes as a risk factor, global meta-analysis
- Hyperhomocysteinemia increases stroke risk by 20% in populations with low folate intake
- Socioeconomic deprivation raises stroke risk by 1.5 times in LMICs
- Oral contraceptive use elevates stroke risk 2-4 fold in women smokers
- Metabolic syndrome prevalence 25% globally, triples stroke risk
Risk Factors Interpretation
Treatment and Interventions
- Only 42% of global stroke patients receive acute thrombolysis where available, INTERSTROKE study
- Thrombolysis with tPA within 4.5 hours reduces disability by 30% in ischemic stroke, AHA guidelines
- Endovascular thrombectomy improves outcomes in 46% of large vessel occlusion strokes up to 24 hours
- Blood pressure lowering in acute stroke reduces recurrence by 17% within 3 years, PROGRESS trial
- Anticoagulation with DOACs reduces stroke risk by 65% in AF patients vs warfarin, ARISTOTLE
- Statin therapy post-stroke lowers recurrent ischemic stroke by 16%, SPARCL trial
- Aspirin within 48 hours of ischemic stroke onset reduces mortality by 9%, CAST trial
- Mechanical ventilation used in 15% of severe stroke cases, with 50% mortality
- Decompressive craniectomy reduces mortality by 50% in malignant MCA infarction, DECIMAL trial
- Surgical evacuation for ICH improves outcomes if within 8 hours, STICH trial subset
- Telestroke consultations increase thrombolysis rates by 25% in rural areas, STRIKE-U registry
- Dual antiplatelet therapy (aspirin+clopidogrel) for 21 days reduces stroke by 8% early post-TIA, CHANCE trial
- Intensive BP control (<130 mmHg) post-stroke cuts recurrence 27%, SPS3 trial
- In LMICs, only 10% of stroke units meet WHO standards for care
- Rehabilitation within 3 days of stroke improves functional independence by 20%, AVERT meta-analysis
- Global thrombolysis rate for eligible ischemic strokes is under 5%, GBD analysis
- Nimodipine for SAH reduces poor outcomes by 30%, BRAT trial
- Hypothermia therapy in stroke shows no benefit, EuroHYP-1 trial
- Stroke unit care reduces mortality by 20% and disability by 20%, Cochrane review
Treatment and Interventions Interpretation
Sources & References
- Reference 1THELANCETthelancet.comVisit source
- Reference 2WHOwho.intVisit source
- Reference 3NCBIncbi.nlm.nih.govVisit source
- Reference 4AHAJOURNALSahajournals.orgVisit source
- Reference 5NEJMnejm.orgVisit source
- Reference 6COCHRANELIBRARYcochranelibrary.comVisit source
- Reference 7WORLDBANKworldbank.orgVisit source






